EA200200775A1 - Псевдополиморф (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она - Google Patents

Псевдополиморф (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она

Info

Publication number
EA200200775A1
EA200200775A1 EA200200775A EA200200775A EA200200775A1 EA 200200775 A1 EA200200775 A1 EA 200200775A1 EA 200200775 A EA200200775 A EA 200200775A EA 200200775 A EA200200775 A EA 200200775A EA 200200775 A1 EA200200775 A1 EA 200200775A1
Authority
EA
Eurasian Patent Office
Prior art keywords
piperidinyl
cis
hydroxy
methyl
psevdopolymorf
Prior art date
Application number
EA200200775A
Other languages
English (en)
Other versions
EA005247B1 (ru
Inventor
Гари Л. Бафус
Кристин М. Харрисон-Боумэн
Гари Л. Силви
Original Assignee
Авентис Фармасьютикалз Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фармасьютикалз Инк. filed Critical Авентис Фармасьютикалз Инк.
Publication of EA200200775A1 publication Critical patent/EA200200775A1/ru
Publication of EA005247B1 publication Critical patent/EA005247B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Stereophonic System (AREA)
  • Inorganic Insulating Materials (AREA)

Abstract

Настоящее изобретение включает псевдополиморф гидрохлорида (-)-цис-2-(2-хлорофенил)-5,7-дигидрокси-8[4R-(3S-гидрокси-1-метил)пиперидинил]-4Н-1-бензопиран-4-она, способ его получения, фармацевтическую композицию и способы применения псевдополиморфа.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200775A 2000-01-18 2001-01-08 Псевдополиморф (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она EA005247B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48471700A 2000-01-18 2000-01-18
PCT/US2001/000519 WO2001053293A1 (en) 2000-01-18 2001-01-08 Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one

Publications (2)

Publication Number Publication Date
EA200200775A1 true EA200200775A1 (ru) 2002-12-26
EA005247B1 EA005247B1 (ru) 2004-12-30

Family

ID=23925305

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200775A EA005247B1 (ru) 2000-01-18 2001-01-08 Псевдополиморф (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она

Country Status (26)

Country Link
EP (1) EP1259507B1 (ru)
JP (1) JP2003520797A (ru)
KR (1) KR100806464B1 (ru)
CN (1) CN1174977C (ru)
AT (1) ATE273303T1 (ru)
AU (1) AU2001226346A1 (ru)
BR (1) BR0107726A (ru)
CA (1) CA2397593C (ru)
CZ (1) CZ301195B6 (ru)
DE (1) DE60104822T2 (ru)
DK (1) DK1259507T3 (ru)
EA (1) EA005247B1 (ru)
ES (1) ES2222332T3 (ru)
HU (1) HUP0204126A3 (ru)
IL (2) IL150638A0 (ru)
MX (1) MXPA02007005A (ru)
NO (1) NO322572B1 (ru)
NZ (1) NZ520280A (ru)
PL (1) PL200696B1 (ru)
PT (1) PT1259507E (ru)
SI (1) SI1259507T1 (ru)
SK (1) SK287404B6 (ru)
TR (1) TR200402036T4 (ru)
TW (1) TWI284129B (ru)
WO (1) WO2001053293A1 (ru)
ZA (1) ZA200205639B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109803684B (zh) 2016-08-23 2022-08-23 卫材 R&D 管理有限公司 用于治疗肝细胞癌的组合疗法
EP4218820A3 (en) 2017-03-16 2023-09-20 Eisai R&D Management Co., Ltd. Combination therapies for the treatment of breast cancer
US20220040324A1 (en) 2018-12-21 2022-02-10 Daiichi Sankyo Company, Limited Combination of antibody-drug conjugate and kinase inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (ru) * 1986-04-11 1989-02-04 Hoechst India
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
ES2222332T3 (es) 2005-02-01
HUP0204126A2 (hu) 2003-04-28
PL356165A1 (en) 2004-06-14
SK287404B6 (sk) 2010-09-07
EP1259507B1 (en) 2004-08-11
CZ301195B6 (cs) 2009-12-02
EA005247B1 (ru) 2004-12-30
TR200402036T4 (tr) 2004-10-21
DK1259507T3 (da) 2004-11-01
PL200696B1 (pl) 2009-01-30
CA2397593C (en) 2009-11-10
WO2001053293A1 (en) 2001-07-26
CZ20022466A3 (cs) 2002-11-13
NO322572B1 (no) 2006-10-30
TWI284129B (en) 2007-07-21
JP2003520797A (ja) 2003-07-08
MXPA02007005A (es) 2004-09-06
PT1259507E (pt) 2004-12-31
CA2397593A1 (en) 2001-07-26
DE60104822D1 (de) 2004-09-16
IL150638A0 (en) 2003-02-12
IL150638A (en) 2009-06-15
KR20020069361A (ko) 2002-08-30
DE60104822T2 (de) 2005-09-01
ZA200205639B (en) 2003-10-15
BR0107726A (pt) 2002-10-01
SI1259507T1 (en) 2005-02-28
SK10362002A3 (sk) 2003-01-09
KR100806464B1 (ko) 2008-02-21
AU2001226346A1 (en) 2001-07-31
NO20023386D0 (no) 2002-07-12
NO20023386L (no) 2002-09-12
HUP0204126A3 (en) 2006-02-28
NZ520280A (en) 2004-04-30
EP1259507A1 (en) 2002-11-27
CN1174977C (zh) 2004-11-10
ATE273303T1 (de) 2004-08-15
CN1395576A (zh) 2003-02-05

Similar Documents

Publication Publication Date Title
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
EA199800857A1 (ru) Композиция для снятия боли и способ снятия боли
EA200200530A1 (ru) Гетероциклические замещенные пиразолоны
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
BR0311823B1 (pt) mÉtodo de determinaÇço de pelo menos um parÂmetro de formaÇço de interesse.
CY1113312T1 (el) Κυκλικοι αναστολεις κινασης τυροσινης πρωτεϊνων
DE60208373D1 (de) Polyaryleneether-polyolefinzusammensetzung, verfahren zu deren herstellung und formassen daraus
EA200300580A1 (ru) Соединения лактама
MY136097A (en) Methods for treating osteoarthritis using an estrogen agonist/antagonist
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
CY1105980T1 (el) Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου
EE04234B1 (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
EE04833B1 (et) Meetod suukaudselt manustatava, Tolperisoni või selle soola sisaldava farmatseutilise preparaadi valmistamiseks
TR199800608A3 (tr) Propanolamin türevleri, bunlarin üretim usulü.
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
EA199800844A1 (ru) Способ получения r-альфа-пропил-пиперониламина и его аналогов, промежуточные продукты, используемые в этом способе
BR9606821A (pt) Processo de racemização para uso na fabricação de levobupivacaina e agentes anestésicos correlacionados de piperidina carboxanilida
DE50204220D1 (de) Verfahren zum Befüllen von im wesentlichen zylinderförmigen Ampullen
ATE516267T1 (de) Vefahren zur herstellung von lactamen
EA200200775A1 (ru) Псевдополиморф (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она
NL1018865A1 (nl) Kathode en werkwijze voor de vervaardiging ervan.
MXPA01009272A (es) Procedimiento de deformacion permanente de materias queratinicas que utiliza un agente absorbente organico.
ATE233323T1 (de) Verfahren zur präparation von enantiomer- angereicherten, n-derivatisierten laktamen.
EA200200776A1 (ru) Этанольный сольват (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она
DK1270576T3 (da) 3-phenyl-3,7-diazabicyclo[3,3,1]nonan-forbindelser samt fremgangsmåde til fremstilling heraf og lægemidler indeholdende sådanne forbindelser

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU